224. An Uncontrollable Leak- The Approach to a VIPoma
The Intern At Work: Internal Medicine
Improving Progression-free Survival with Peptide Receptor Radionuclide Therapy
Exploring the benefits of 177 ludotate in treating mid-gut neuroendocrine tumors, showcasing improved progression-free survival rates compared to octreotide LAR, and highlighting potential solutions for Vipomas.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
